Pfizer’s chief executive, Albert Bourla, told investors that the uncertainty surrounding President Donald Trump’s proposed tariffs on imported medicines is keeping the company from investing more in U.S. factories and research labs. Speaking during Pfizer’s first-quarter earnings call on Tuesday, Bo...